Why Analysts are Rating Alkermes (ALKS) a Buy [Yahoo! Finance]
Alkermes plc - Ordinary Shares (ALKS)
Last alkermes plc - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-irhome
Company Research
Source: Yahoo! Finance
At the close of play on December 19, the consensus ratings remain bullish for Alkermes plc (NASDAQ:ALKS). The stock has been covered by 15 analysts, of which 11 assigned it Buy ratings and the remaining 4 were Holds. As per analyst estimates, the forecasted median 1-year price target for the stock is $46.17 a share, resulting in 62.3% upside potential at the prevailing prices. Likoper/Shutterstock.com On December 3, the company Chairman and CEO, Richard Pops, presented at the Evercore 8th Annual Healthcare Conference. He described 2025 as a truly transformational year for the business. Apart from positive NT1 and NT2 data, he also spoke about the company's aggressive pursuits within the hypersomnolence market. Alkermes (NASDAQ:ALKS) plans to acquire Avadel, a profitable company with a circa $275 million topline. Pops linked this strategic acquisition with their planned launch of alixorexton, an oral drug for treating complex sleep disorders. On December 5, Piper Sandler analyst
Show less
Read more
Impact Snapshot
Event Time:
ALKS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALKS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALKS alerts
High impacting Alkermes plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ALKS
News
- Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Trends and Market Growth Opportunities in the Alcohol Use Disorder Industry, 2025-2032 [Yahoo! Finance]Yahoo! Finance
- Alkermes (NASDAQ:ALKS) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c+)" rating to a "buy (b-)" rating.MarketBeat
- Alkermes to Participate in Two Upcoming Investor ConferencesBusiness Wire
ALKS
Earnings
- 10/28/25 - Beat
ALKS
Sec Filings
- 12/5/25 - Form 4
- 12/3/25 - Form 144
- 12/1/25 - Form 4
- ALKS's page on the SEC website